CD19 CAR-Targeted T Cells Induce Long-Term Remission and B Cell Aplasia in an Immunocompetent Mouse Model of B Cell Acute Lymphoblastic Leukemia

• Marco L. Davila,

  Affiliations Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Christopher C. Kloss,

  Affiliations Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Biochemistry, Cell, and Molecular Biology Program, Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, New York, United States of America

  ⨯
• Gertrude Gunset,

  Affiliation Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Michel Sadelain

  * E-mail: m-sadelain@ski.mskcc.org

  Affiliations Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯